Latest news with #SYRE
Washington Post
6 days ago
- Business
- Washington Post
Spyre Therapeutics: Q2 Earnings Snapshot
WALTHAM, Mass. — WALTHAM, Mass. — Spyre Therapeutics, Inc. (SYRE) on Tuesday reported a loss of $36.7 million in its second quarter. The Waltham, Massachusetts-based company said it had a loss of 49 cents per share. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 73 cents per share.
Washington Post
27-02-2025
- Business
- Washington Post
Spyre Therapeutics: Q4 Earnings Snapshot
WALTHAM, Mass. — WALTHAM, Mass. — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a loss of 81 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.
